Back

Key comorbidities and laboratory findings: insights from first prospective, observational and Multi-Center Malaysia Heart Failure (MYHF) registry

2 December 2022 (10:54 - 11:00)
Organised by:
Congress Presentation Part of: Special Populations Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Asia 2022 with APSC & AFC

About the speaker

Photo
Professor Wan Azman Wan Ahmad

University Malaya Medical Centre (UMMC), Kuala Lumpur (Malaysia)

3 More presentations in this session

Presentation thumbnail
An updated meta-analysis: The effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the mortality of hypertensive patients with confirmed COVID-19 infection
Doctor M. Manalili Pamplona (San Juan, PH)
Abstract Slides
Presentation thumbnail
HbA1c variability is associated with adverse outcomes in heart failure patients with and without diabetes
Doctor Q. Ren (Hong Kong, HK)
Abstract
Presentation thumbnail
Prevalence, mortality, and disability-adjusted-life-years resulting from aortic aneurysm burden and its association with the socio-demographic index in Asia, 1990-2019: Results from the GBD 2019
Professor L. Gobolos (Abu Dhabi, AE)
Slides

Access the full session

Session thumbnail
Special Populations

The Event

Event poster

ESC Asia 2022 with APSC & AFC

2 December 2022 10:54 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources